Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
about
p38 MAPK signaling in postnatal tendon growth and remodelingAdriamycin nephropathy: a failure of endothelial progenitor cell-induced repair.Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation.Cell models to study regulation of cell transformation in pathologies of retinal pigment epitheliumResveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3Maternal obesity induces fibrosis in fetal myocardium of sheepResolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylationSalinomycin and other polyether ionophores are a new class of antiscarring agentSelective p38α mitogen-activated protein kinase inhibitor attenuates lung inflammation and fibrosis in IL-13 transgenic mouse model of asthma.Induced autologous stem cell transplantation for treatment of rabbit renal interstitial fibrosisA cell-based screening assay to identify pharmaceutical compounds that enhance the regenerative quality of corneal repair.Experimental Mouse Model of Lumbar Ligamentum Flavum Hypertrophy.P311 promotes renal fibrosis via TGFβ1/Smad signaling.The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis.Macrophage diversity in renal injury and repair.The role of stress-activated protein kinase signaling in renal pathophysiology.Chronic kidney disease growth factors in renal fibrosis.The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease.Triptolide inhibits extracellular matrix protein synthesis by suppressing the Smad2 but not the MAPK pathway in TGF-beta1-stimulated NRK-49F cells.Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.Renoprotective action of a matrix metalloproteinase inhibitor in progressive mesangioproliferative nephritis.Altering equine corneal fibroblast differentiation through Smad gene transfer.Postconditioning protects renal fibrosis by attenuating oxidative stress-induced mitochondrial injury.Synergistic action of inflammation and lipid dysmetabolism on kidney damage in rats.Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
P2860
Q28544034-5EFB4497-08B3-4777-8FA3-B3BBD18017C1Q33745142-84B53DB3-2AC1-4A28-AB02-1BB60BB7EDDDQ33916545-D503DB4E-086B-45BC-BC13-7357CAEB77AFQ34080190-7588A4D6-968F-4423-BEB0-DF2BAF50A2D2Q34086829-D8A6EB26-8831-404A-AF25-8FE5FF650205Q34425988-E45B9077-67CF-4640-B174-E2C628929BDDQ34807449-FE07B3CD-CA09-47B1-BD49-4818AFDD6467Q35055573-13A30C4D-6CD7-4328-A5D5-9BDF72CF0F1BQ35062983-CF4E218F-7990-4227-9296-E2A6A8A00DBDQ35075572-3DCE1F03-EF16-4961-AD35-B7520EB37A42Q35863488-BEC27E49-CA10-4B1B-8884-7D32C529613CQ36242766-F977EAA1-8F4D-4115-BA67-1C2FE36B01ADQ36330422-E5D1CB5E-7AA1-44D7-933F-1C94DE138015Q36479962-95934726-DC3F-472F-B0A7-143C145FA379Q36842393-B6CA6BE2-ACF1-4CCE-971D-85B70B97E7CBQ36955562-9CB09946-AE85-4B78-B88E-80B9DBBEC643Q37316623-ABF3FB0B-5A6E-4D08-A35A-853D78DF90F6Q37833133-B6CBE92D-6839-4C14-835D-5EF0D87737F2Q37940031-614E5DF6-05F3-4114-A496-31215A480965Q39704229-5C105F54-D5EF-4864-A511-107E39D1A860Q41425182-832873CB-C82A-402F-9852-C861B2E69600Q42074338-693D14B2-DEF0-4A1B-80D3-5CDA65F98EFBQ42088862-C2B33E44-F41B-4F62-A403-9079643560CAQ45869534-5254C8C4-4B19-4383-BFB6-9E407FFE4E18Q46397391-8BEE0392-A859-402B-B79A-C08E53194553Q54250055-53E445D8-2DF8-4EF4-A8F9-4AC0A98CD826Q54484920-41EBFC65-C123-40B7-AC00-1950C0BD65BA
P2860
Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Inhibition of p38 mitogen-acti ...... driamycin-induced nephropathy.
@ast
Inhibition of p38 mitogen-acti ...... driamycin-induced nephropathy.
@en
type
label
Inhibition of p38 mitogen-acti ...... driamycin-induced nephropathy.
@ast
Inhibition of p38 mitogen-acti ...... driamycin-induced nephropathy.
@en
prefLabel
Inhibition of p38 mitogen-acti ...... driamycin-induced nephropathy.
@ast
Inhibition of p38 mitogen-acti ...... driamycin-induced nephropathy.
@en
P2093
P2860
P50
P1476
Inhibition of p38 mitogen-acti ...... adriamycin-induced nephropathy
@en
P2093
Naomi Vittoria Campanale
Rong Jiao Liang
P2860
P304
P356
10.2353/AJPATH.2006.060169
P407
P577
2006-11-01T00:00:00Z